Herpesviruses DUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease

Overview

Journal Pathogens

Date 2016 Dec 31

PMID 28036046

Citations 18

Authors

Marshall V Williams

Brandon Cox

Maria Eugenia Ariza

Affiliations

Soon will be listed here.

Abstract

The human herpesviruses are ubiquitous viruses and have a prevalence of over 90% in the adult population. Following a primary infection they establish latency and can be reactivated over a person's lifetime. While it is well accepted that human herpesviruses are implicated in numerous diseases ranging from dermatological and autoimmune disease to cancer, the role of lytic proteins in the pathophysiology of herpesvirus-associated diseases remains largely understudies. Only recently have we begun to appreciate the importance of lytic proteins produced during reactivation of the virus, in particular the deoxyuridine triphosphate nucleotidohydrolases (dUTPase), as key modulators of the host innate and adaptive immune responses. In this review, we provide evidence from animal and human studies of the Epstein-Barr virus as a prototype, supporting the notion that herpesviruses dUTPases are a family of proteins with unique immunoregulatory functions that can alter the inflammatory microenvironment and thus exacerbate the immune pathology of herpesvirus-related diseases including myalgic encephalomyelitis/chronic fatigue syndrome, autoimmune diseases, and cancer.

Citing Articles

Control of HSV-1 Infection: Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics.

Sosnovtseva A, Demidova N, Klimova R, Kovalev M, Kushch A, Starodubova E Int J Mol Sci. 2024; 25(22).

PMID: 39596412 PMC: 11595115. DOI: 10.3390/ijms252212346.

A proteome-wide structural systems approach reveals insights into protein families of all human herpesviruses.

Soh T, Ognibene S, Sanders S, Schaper R, Kaufer B, Bosse J Nat Commun. 2024; 15(1):10230.

PMID: 39592652 PMC: 11599850. DOI: 10.1038/s41467-024-54668-2.

Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.

Gaspar Z, Szabo B, Cegledi A, Lakatos B Geroscience. 2024; 47(1):167-187.

PMID: 39207648 PMC: 11872864. DOI: 10.1007/s11357-024-01323-9.

Diverse Expression Patterns of EBV Oncogenes () in EBV Associated Gastric Carcinoma and their Association with Viral Loads.

Soltani M, Nejati A, Marashi S, Nili F, Yaseri M, Mokhtari Azad T Arch Razi Inst. 2023; 78(2):643-649.

PMID: 37396720 PMC: 10314258. DOI: 10.22092/ARI.2022.359408.2415.

Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.

Vojdani A, Vojdani E, Saidara E, Maes M Viruses. 2023; 15(2).

PMID: 36851614 PMC: 9967513. DOI: 10.3390/v15020400.

References

Komaroff A, Cho T . Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol. 2011; 31(3):325-37. DOI: 10.1055/s-0031-1287654. View

Laney A, Cannon M, Jaffe H, Offermann M, Ou C, Radford K . Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma. AIDS. 2007; 21(12):1541-5. DOI: 10.1097/QAD.0b013e3282202b7d. View

Loebel M, Strohschein K, Giannini C, Koelsch U, Bauer S, Doebis C . Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome. PLoS One. 2014; 9(1):e85387. PMC: 3893202. DOI: 10.1371/journal.pone.0085387. View

Lerner A, Ariza M, Williams M, Jason L, Beqaj S, Fitzgerald J . Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. PLoS One. 2012; 7(11):e47891. PMC: 3498272. DOI: 10.1371/journal.pone.0047891. View

Davison A, Stow N . New genes from old: redeployment of dUTPase by herpesviruses. J Virol. 2005; 79(20):12880-92. PMC: 1235826. DOI: 10.1128/JVI.79.20.12880-12892.2005. View

Waldman W, Williams Jr M, Lemeshow S, Binkley P, Guttridge D, Kiecolt-Glaser J . Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk. Brain Behav Immun. 2007; 22(2):215-23. PMC: 2245868. DOI: 10.1016/j.bbi.2007.07.007. View

Theorell T, Blomkvist V, Lindh G, Evengard B . Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med. 1999; 61(3):304-10. DOI: 10.1097/00006842-199905000-00009. View

Madrid A, Ganem D . Kaposi's sarcoma-associated herpesvirus ORF54/dUTPase downregulates a ligand for the NK activating receptor NKp44. J Virol. 2012; 86(16):8693-704. PMC: 3421743. DOI: 10.1128/JVI.00252-12. View

Kogelnik A, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, Montoya J . Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. J Clin Virol. 2007; 37 Suppl 1:S33-8. DOI: 10.1016/S1386-6532(06)70009-9. View

10.

Ablashi D, Eastman H, Owen C, Roman M, Friedman J, Zabriskie J . Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000; 16(3):179-91. DOI: 10.1016/s1386-6532(99)00079-7. View

11.

Draborg A, Duus K, Houen G . Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol. 2013; 2013:535738. PMC: 3766599. DOI: 10.1155/2013/535738. View

12.

Komaroff A . Is human herpesvirus-6 a trigger for chronic fatigue syndrome?. J Clin Virol. 2007; 37 Suppl 1:S39-46. DOI: 10.1016/S1386-6532(06)70010-5. View

13.

Halpin P, Williams M, Klimas N, Fletcher M, Barnes Z, Ariza M . Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology. J Med Virol. 2017; 89(9):1636-1645. PMC: 5513753. DOI: 10.1002/jmv.24810. View

14.

Szomolanyi-Tsuda E, Liang X, Welsh R, Kurt-Jones E, Finberg R . Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol. 2006; 80(9):4286-91. PMC: 1472014. DOI: 10.1128/JVI.80.9.4286-4291.2006. View

15.

Doitsh G, Galloway N, Geng X, Yang Z, Monroe K, Zepeda O . Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2013; 505(7484):509-14. PMC: 4047036. DOI: 10.1038/nature12940. View

16.

Jones R, Seaman W, Feng W, Barlow E, Dickerson S, Delecluse H . Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int J Cancer. 2007; 121(6):1274-81. DOI: 10.1002/ijc.22839. View

17.

Scholz B, Harth-Hertle M, Malterer G, Haas J, Ellwart J, Schulz T . Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines. PLoS Pathog. 2013; 9(5):e1003336. PMC: 3656114. DOI: 10.1371/journal.ppat.1003336. View

18.

Hoeppli R, Wu D, Cook L, Levings M . The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome. Front Immunol. 2015; 6:61. PMC: 4332351. DOI: 10.3389/fimmu.2015.00061. View

19.

Wallace 2nd H, Natelson B, Gause W, Hay J . Human herpesviruses in chronic fatigue syndrome. Clin Diagn Lab Immunol. 1999; 6(2):216-23. PMC: 95690. DOI: 10.1128/CDLI.6.2.216-223.1999. View

20.

Sutmuller R, Den Brok M, Kramer M, Bennink E, Toonen L, Kullberg B . Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest. 2006; 116(2):485-94. PMC: 1332026. DOI: 10.1172/JCI25439. View